Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Info

Ejection Fraction

  • change in ejection fraction, would expect a decline in EF of 2-3% per year, concerning if rapid progression, i.e., 10% decline or more

NTproBNP

  • % change over a period of time – a decrease is correlated with improvement, measured annually

SDTM Examples: Basic CMR Tests for Systolic Function

This section illustrates example analysis datasets for the following endpoints:

  • Percent change in ejection fraction over time
  • Decline in ejection fraction over a time period (1 year) grouped by a decline greater than 10.0%
  • Percent change in NTproBNP over a period of time (1 year)

Source Data

The SDTM examples used as the source data are from Section 2.1, Basic CMR Tests for Systolic Function. The CV dataset contains 16 rows, 1-8 for visit 1 and 9-16 for visit 6. Of these rows, the CVTESTCD = "LVEF_C" and CVTESTCD = "RVEF_C" representing the Ventricular Ejection Fraction, Calculated (%) for left and right were selected for the analysis. The LB dataset test where LBTESTCD = "BNPPRONT" was used to add the value of BNPPRONT to compute the percent change over time, and then it was added as a potential covariate in each row for the last analysis. As in all ADaM datasets, the Subject Level Analysis Dataset (ADSL) was merged in to the SDTM datasets to capture all the necessary demographics, treatments and other required variables for analysis of the data.

Example Analysis Datasets

The analysis datasets for this example include treatment and demographic information drawn from the Subject Level Analysis Dataset (ADSL), defined in the Metadata Tables below. Only some of the required variables from ADSL are shown for illustrative purposes. The ADSL incorporates demographics, treatment groups, study dates, and stratification variables. Additional information on the ADSL can be found in Section 2.3.1 of the ADaM Implementation Guide (ADaMIG) v1.3.

The ADSL is combined with other SDTM dataset to create the analysis datasets. More than one SDTM dataset can be combined in this way. Also, stratification variables can be created in the ADSL to subset by, or to add variables needed in the analyses. For instance, stratification variable might be type of concomitant medications, such as an ACE inhibitors. for this we added a flag ACEMEDFL, which is coded Y or N. Another variable added; body surface area (BSABL), is derived from the LB dataset at the baseline visit and added to ADSL. However, when the subjects are children, the body surface area changes over time. Therefore, an additional non-standard variable is added to the analysis dataset with the subject's current BSA by visit. 

The ADCVNTP dataset includes tests pertinent to these analyses. The record LB are selected where CVTESTCD is equal to "LVEF_C" or "RVEF_C". It also includes a subset of the Laboratory Results (LB) SDTM dataset, for which LBTESTCD is equal to "BNPPRONT". The relationship dataset RELREC illustrates the relationship between datasets. In this case, many lab draws may occur throughout the year, but only those linked to a specific visit are included. By subsetting the LB dataset with LBLNKID not missing, laboratory data that aligns with CV data can be filtered out and sorted using USUBJID and VISIT. If LBLNKID is not available, a windowing strategy could be used to select the laboratory draw closest to that visit for merging with CV, computed in AVISIT. In the example, only two LB records are shown which are linked to CV where CVTESTCD = "LVEF_C" or CVTESTCD = "R.VEF_C"

ADCVMR is an efficacy analysis dataset with only a few records for more complex modeling of changes in ejection fraction, plus the ProB-type test results. It is an ADaM Basic Data Structure (BDS) dataset, with additional variables added from ADCVNTP.

The tableS below showsthe example analysis dataset metadata and parameters used for the analysis. 

Definexmltable
Multipletrue
LevelDataset
PurposeAnalysis

Dataset Name

Dataset Description

Class of Dataset

Structure

Location

Keys

Documentation

ADSL

Subject-Level Analysis Dataset

SUBJECT LEVEL ANALYSIS DATASET

One record per subject

adsl.xptUSUBJIDADaMIG
ADCVNTPCardiac Ejection Fraction and NTproBNP Analysis Dataset

BASIC DATA STRUCTURE

One record per subject per analysis visit per parameteradcvntp.xptUSUBJID, AVISITN, PARAMN

Analysis Dataset

ADCVCMRCardiovascular CMR Ejection Fraction Analysis Dataset

BASIC DATA STRUCTURE

One record per subject per analysis visit per parameteradcvcmr.xptUSUBJID, AVISITN, PARAMN

Analysis Dataset

ADSL Analysis Dataset

This is a simplified example ADSL dataset; it is expected that additional variables for stratification or of interest for analysis would be included.

Definexmltable
DatasetADSL
LevelVariable
PurposeAnalysis
NameVariable
Variable NameVariable LabelTypeCodelist/Controlled Terms/FormatSourceDerivation/Comment
STUDYIDStudy IdentifierChar

DM.STUDYID


USUBJIDUnique Subject IdentifierChar

DM.USUBJID


BRTHDTDate of BirthNumdate9.

ADSL.BRTHDTC

Convert BRTHDTC from ISO 8601 format to numeric date. (Note that if exact date is not found then use two variables to capture year and month.)
TRTSDTDate of First Exposure to TreatmentNumdate9.
Date portion of DM.RFSTDTC converted to numeric and displayed in a format such as DATE9.
TRT01P

Planned Treatment for Period 01

CharTreatment AADSL.TRT01PFor this example we are using "Treatment A". In a Real World Evidence study this could be non-treatment related, e.g. "Group A".

ITTFL

Intent-To-Treat Population Flag

Char

Y; N

ADSL.ITTFL

Derive the intent-to-treat population as per the protocol and SAP.
BSABASEBody Surface Area (m2) at BaselineNum
ADSL.BSABASE

Set to VS.VSSTRESN in ADSL where VS.VSTESTCD = "BSA" and select for baseline visit.

ACEINHFL

ACE Inhibitor Medications Flag

Char

Y


Select a list of ACE inhibitor medications from concomitant medications (CM) domain, and from treatment (EX or EC) domains. Code 'Y' if the medication was taken during the study. Can be used to subset or to exclude the population who took ACE inhibitors.

Dataset wrap
Showtrue
NameADSl
Dataset2
tableidadcvcmr
RowSTUDYIDUSUBJIDBRTHDTTRTSDTTRT01PITTFLBSABASEACENHFL
1DMD-EFLGEDMD-EFLGE-10115FEB202116MAY2022Treatment AY0.65Y
Definexmltable
DatasetADCVNTP
LevelValue
PurposeAnalysis
OIDAVAL
DatasetVariableWhereTypeOriginDerivation/Comment
ADCVNTPAVALPARAMCD = "LVEFC"NumPredecessorSet to CV.CVSTRESN where CV.CVTESTCD = "LVEF_C"
ADCVNTPAVALPARAMCD = "RVEFC"NumPredecessorSet to CV.CVSTRESN where CV.CVTESTCD = "RVEF_C"
ADCVNTPAVALPARAMCD = "BNPPRONT"NumPredecessorSet to LB.LBSTRESN where LB.LBTESTCD = "BNPPRONT"

Analysis Datasets for Ejection Fraction

The subsequent section provides the data structures for the example ADaM datasets. In this example, columns for derived variables BASE, CHG, PCHG and CHGCAT1 have been added to facilitate analyses of the efficacy endpoints. Specifically, example demographic data for ADSL were created for an 8 year old male. Also, a custom variable for BSA at baseline (BSABASE), and an example of a stratification variable for subjects with was added from ADSL.

Definexmltable
DatasetADCVNTP
LevelVariable
PurposeAnalysis
NameVariable
Variable NameVariable LabelTypeCodelist/Controlled Terms/FormatSourceDerivation/Comment
STUDYIDStudy IdentifierChar

CV.STUDYID


USUBJIDUnique Subject IdentifierChar

CV.USUBJID

Select for records with RE data.
ASEQAnalysis Sequence NumberNum

CV.CVSEQ

Number records 1 to n after sorting by keys.
BRTHDTDate of BirthNumDate9.

ADSL.BRTHDTC

Convert BRTHDTC from ISO 8601 format to numeric date. (Note that if exact date is not found then use two variables to capture year and month.)
TRT01P

Planned Treatment for Period 01

CharTreatment AADSL.TRT01PFor this example we are using "Treatment A". In a Real World Evidence study this could be non-treatment related, e.g. "Group A".

ITTFL

Intent-To-Treat Population Flag

Char

Y; N

ADSL.ITTFL


BSABASEBody Surface Area (m2) at BaselineNum
ADSL.BSABASECompute in ADSL where VS.VSTESTCD = "BSA".

ACEINHFL

ACE Inhibitor Medications Flag

Char

Y


Select a list of ACE inhibitor medications from concomitant medications (CM) domain, and from treatment (EX or EC) domains. Code 'Y' if the medication was taken during the study. Can be used to subset or to exclude the population who took ACE inhibitors.

BSABody Surface Area (m2) by VisitNum



Compute from VS.HEIGHT and VS.WEIGHT by visit, using the Du Bois method. Note that there are multiple methods to compute, and the study protocol should describe which one to use. (e.g. other methods may be Mosteller, Haycock, Gehan & George, Boyd, Fujimoto, Takahira, and Schlich)

PARAMParameterChar

Left Ventricular Ejection Fraction, Calculated (%);

Right Ventricular Ejection Fraction, Calculated (%);

N-Terminal ProB-type Natriuretic Peptide (pg/mL)


For tests from CV, set to the values of CV.CVTEST plus CV.CVTESTU with spaces and parentheses as shown. 

For tests from LB, set to the value of LB.LBTEST plus LB.LBTESTU with spaces and parentheses as shown. 

PARAMCDParameter CodeChar

LVEFC;

RVEFC;

BNPPRONT


If CV.CVTESTCD = "LVEF_C" then PARAMCD = "LVEFC"

If CV.CVTESTCD = "RVEF_C" then PARAMCD = "RVEFC"

If LB.LBTESTDC = "BNPPRONT" then PARAMCD = "BNPPRONT

Note: for this example dataset, select the records where the test values shown above are included.

PARAMNParameter (N)Num



Number PARAMCD as follows:

LVEFC = "1"

RVEFC = "2"

BNPPRONT = "3"

AVALAnalysis ValueNum


See Parameter Value List 

AVISITAnalysis VisitChar



If CV.VISIT = "VISIT 1" then AVISIT = "Visit 1 (Baseline)".

Else if CV.VISIT = "VISIT 6" then AVISIT = "Visit 6 (1 Year)".

AVISITNAnalysis Visit (N)Num

Set to value of CV.VISITNUM or LB.VISITNUM
VISITVisitNum

CV.VISIT

LB.VISIT


ADTAnalysis DateNumdate9.
Date portion of CV.CVDTC or LB.LBDTC converted to numeric and displayed in a format such as date9. 
ABLFLBaseline Record FlagCharY

If CV.VISIT = 1 then ABLFL = "Y".

BASEBaseline ValueNum

Set BASE to AVAL from the record for that subject and parameter where ABLFL = "Y".

Populate BASE for additional visits by copying the value of BASE in the baseline record by USUBJID and ADT. (Or by AVISIT if ADT varies for labs, where windowing is applied to select record closest to the visit)

CHGChange from BaselineNum

Compute CHG = AVAL - BASE for that record. Only compute for post-baseline records.
PCHGPercent Change from BaselineNum

Compute PCHG = (CHG / BASE) * 100. Only compute for post-baseline records.
CHGCAT1Change from Baseline Category 1Char

Decline >=10.0;

Decline < 10.0; 

Increase


Categorize the value of CHG for Left Ventricular Ejection Fraction, and Calculated (%) (LVEFC) and for Right Ventricular Ejection Fraction, Calculated (%) (RVEFC)
CHGCAT2Change from Baseline Category 2Chart



Categorize the value of CHG for N-Terminal ProB-type Natriuretic Peptide (pg/mL) (BNPPRONT)
SRCDOMSource DataChar

CV; LB


Set to the SDTM domain name that relates to the analysis value.
SRCSEQSource Sequence NumberNum


CV.CVSEQ

LB.LBSEQ

Set to the SDTM domain sequence number that relates to the analysis value.

Example 1 

This example dataset shows the findings and additional analysis variables associated with:

  • Left Ventricular Ejection Fraction, Calculated (%)
  • Right Ventricular Ejection Fraction, Calculated (%)
  • N-Terminal ProB-type Natriuretic Peptide (pg/mL)
Dataset wrap
Nameadcvntp
Rowcaps
Rows 1-2:Show the baseline ejection fraction measurements at VISIT 1.
Row 3:Shows the baseline N-Terminal ProB-type Natriuretic Peptide test results at VISIT 1.
Rows 4-5:Show the baseline ejection fraction measurements at VISIT 6.
Row 6:Shows the baseline N-Terminal ProB-type Natriuretic Peptide test results at VISIT 6.
Dataset2
tableidadcvntp
RowSTUDYIDUSUBJIDASEQBRTHDTTRT01PITTFLBSABASEACEINHFLBSAPARAMPARAMCDPARAMNAVALAVISITAVISITNVISITADTABLFLBASECHGPCHGCHGCAT1SRCDOMSRCSEQ
1DMD-EFLGEDMD-EFLGE-101115FEB2021Treatment AY0.65Y0.65Left Ventricular Ejection Fraction, Calculated (%)LVEFC167Visit 1 (Baseline)1VISIT 116MAY2022Y67


CV3
2DMD-EFLGEDMD-EFLGE-101215FEB2021Treatment AY0.65Y
Right Ventricular Ejection Fraction, Calculated (%)RVEFC274Visit 1 (Baseline))1VISIT 116MAY2022Y74


CV7
3DMD-EFLGEDMD-EFLGE-101315FEB2021Treatment AY0.65Y
N-Terminal ProB-type Natriuretic Peptide (IU/L)BNPPRONT340Visit 1 (Baseline)1VISIT 116MAY2022Y40


LB1
4DMD-EFLGEDMD-EFLGE-101415FEB2021Treatment AY0.65Y
Left Ventricular Ejection Fraction, Calculated (%)LVEFC160Visit 6 (1 Year)6VISIT 601JUN2023
67-7-10.447761Decline >=10.0CV11
5DMD-EFLGEDMD-EFLGE-101515FEB2021Treatment AY0.65Y
Right Ventricular Ejection Fraction, Calculated (%)RVEFC261Visit 6 (1 Year)6VISIT 601JUN2023
74-13-17.567568Decline >=10.0CV15
6DMD-EFLGEDMD-EFLGE-101615FEB2021Treatment AY0.65Y
N-Terminal ProB-type Natriuretic Peptide (IU/L)BNPPRONT3900Visit 6 (1 Year)6VISIT 101JUN2023
408602,150
LB2

Example 2 

The dataset above can also be set up to provide multivariate analyses by taking the lab tests of interest, transposing and merging with the ADCVNTP dataset. In that case, the records from LB are not needed as a row.

DatasetValueWhere Variable Variable Label
ADCVCMRAVALPARAMCD = "BNPPRONT"BNPPRONTN-Terminal ProB-type Natriuretic Peptide (IU/L)
ADCVCMRCHGPARAMCD = "BNPPRONT"BNPCHGN-Term ProB-type N Pep Change Category
Dataset wrap
Nameadcvcmr
Dataset2
tableidadcvcmr
RowSTUDYIDUSUBJIDASEQTRT01PITTFLBSABASEACEINHFLBSABNPPRONTBNPCHGPARAMPARAMCDPARAMNAVALAVISITAVISITNVISITADTABLFLBASECHGPCHGSRCDOMSRCSEQ
1DMD-EFLGEDMD-EFLGE-1011Treatment AY0.65Y
40
Left Ventricular Ejection Fraction, Calculated (%)LVEFC167Visit 1 (Baseline)1VISIT 116MAY2022Y67

CV3
2DMD-EFLGEDMD-EFLGE-1012Treatment AY0.65Y
40
Right Ventricular Ejection Fraction, Calculated (%)RVEFC274Visit 1 (Baseline)1VISIT 116MAY2022Y74

CV7
3DMD-EFLGEDMD-EFLGE-1013Treatment AY0.65Y
9002150Left Ventricular Ejection Fraction, Calculated (%)LVEFC160Visit 6 (1 Year)6VISIT 601JUN2023
67-7-10.447761CV11
4DMD-EFLGEDMD-EFLGE-1014Treatment AY0.65Y
9002150Right Ventricular Ejection Fraction, Calculated (%)RVEFC261Visit 6 (1 Year)6VISIT 601JUN2023
74-13-17.567568CV15

Example Analysis Results Metadata (ARM) Tables

For more details on ARM, see the ADaMIG and the Analysis Results Metadata (ARM) v1.0 for Define-XML v2.0 (https://www.cdisc.org/standards/foundational/adam).

Table 1

Display

Table 14.xx.xx Percent Change in Left Ventricular Ejection Fraction Over Time

Analysis ResultComparison of Percent Change of Ejection Fraction for the Treatment Groups Over Time (quarterly or yearly)
Analysis Variables(s)PCHG
Analysis ReasonPrimary efficacy endpoint as prespecified in the SAP
Analysis PurposePrimary outcome measure

Data References

(incl. selection criteria)

PARAMCD = "LVEFC"

Where ITTFL = "Y"

Documentation

 The mixed model using lsmeans to compare treatment groups

Programming Statements 

(Add programming language statements here: SAS, R, etc.)

PROC MIXED DATA=ADCVCMR;

CLASS STUYDID TRT01P AVISITN;

MODEL PCHG=AVISITN*TRT01P/Solution;

RANDOM INTERCEPT / SUBJECT=STUYDID TYPE=UN;

LSMEANS TRT01P*AVISITN/ CL PDIFF;

RUN;


Table 2, ADD SOME COVARIATES TO THE MODEL

Display

Table 14.xx.xx Percent Change in Left Ventricular Ejection Fraction Over Time

Analysis ResultComparison of Percent Change of Ejection Fraction for the Treatment Groups Over Time (quarterly or yearly)
Analysis Variables(s)PCHG
Analysis ReasonPrimary efficacy endpoint as prespecified in the SAP
Analysis PurposePrimary outcome measure

Data References

(incl. selection criteria)

PARAMCD = "LVEFC"

Where ITTFL = "Y"

Documentation

 The mixed model using lsmeans to compare treatment groups

Programming Statements 

(Add programming language statements here: SAS, R, etc.)

PROC MIXED DATA=ADCVNTP;

CLASS STUYDID TRT01P AVISITN;

MODEL PCHG=AVISITN*TRT01P/Solution;

RANDOM INTERCEPT / SUBJECT=STUYDID TYPE=UN;

LSMEANS TRT01P*AVISITN/ CL PDIFF;

RUN;


Move to table 3  This example uses the dataset ADCVNTP, selecting for the parameter "N-Terminal ProB-type Natriuretic Peptide (IU/L)".

Display

Table 14.xx.xx Percent change in NTproBNP over a period of time (yearly)

Analysis ResultComparison of Percent Change of NTproBNP for the Treatment Groups Over Time (yearly)
Analysis Variables(s)PCHG
Analysis ReasonPrimary efficacy endpoint as prespecified in the SAP
Analysis PurposePrimary outcome measure

Data References

(incl. selection criteria)

PARAMCD = "BNPPRONT"

Where ITTFL = "Y"

Documentation

 The mixed model using lsmeans to compare treatment groups

Programming Statements 

(Add programming language statements here: SAS, R, etc.)

PROC MIXED DATA=ADCVNTP;

WHERE PARAMCD = "BNPPRONT";

CLASS STUYDID TRT01P AVISITN;

MODEL PCHG=AVISITN*TRT01P/Solution;

RANDOM INTERCEPT / SUBJECT=STUYDID TYPE=UN;

LSMEANS TRT01P*AVISITN/ CL PDIFF;

RUN;

Pagenav2